insights_auto
Why is BEAM down 4,29%?
Dive Deeperchevron_right
BEAM:BMV
Beam Therapeutics Inc
453,00 MX$
arrow_downward
-4,29%(-20,30) 1D
8 հոկ, 07:30:20 GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2,52 մլրդ
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MX$
52-wk low
384,79 MX$
No. of employees
540
Mkt. cap
2,52 մլրդ
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MX$
52-wk low
384,79 MX$
No. of employees
540
News stories
From web sources and news partners
Investing.com Canada
·
14 ժամ առաջ
Beam Therapeutics reports early data on gene therapy for GSDIa By Investing.com
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc